- Home
- WYY vs PASG Comparison
WYY vs PASG Comparison
Compare WYY & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- PASG
- Stock Information
- Founded
- WYY 1991
- PASG 2017
- Country
- WYY United States
- PASG United States
- Employees
- WYY N/A
- PASG N/A
- Industry
- WYY EDP Services
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- PASG Health Care
- Exchange
- WYY Nasdaq
- PASG Nasdaq
- Market Cap
- WYY 35.6M
- PASG 31.1M
- IPO Year
- WYY 1998
- PASG 2020
- Fundamental
- Price
- WYY $3.01
- PASG $0.43
- Analyst Decision
- WYY Strong Buy
- PASG Strong Buy
- Analyst Count
- WYY 1
- PASG 3
- Target Price
- WYY $7.00
- PASG $7.67
- AVG Volume (30 Days)
- WYY 210.9K
- PASG 376.9K
- Earning Date
- WYY 05-15-2025
- PASG 05-13-2025
- Dividend Yield
- WYY N/A
- PASG N/A
- EPS Growth
- WYY N/A
- PASG N/A
- EPS
- WYY N/A
- PASG N/A
- Revenue
- WYY $142,582,209.00
- PASG N/A
- Revenue This Year
- WYY $10.84
- PASG N/A
- Revenue Next Year
- WYY $12.37
- PASG N/A
- P/E Ratio
- WYY N/A
- PASG N/A
- Revenue Growth
- WYY 24.03
- PASG N/A
- 52 Week Low
- WYY $2.19
- PASG $0.26
- 52 Week High
- WYY $6.25
- PASG $1.33
- Technical
- Relative Strength Index (RSI)
- WYY 35.88
- PASG 64.10
- Support Level
- WYY $2.90
- PASG $0.34
- Resistance Level
- WYY $3.27
- PASG $0.47
- Average True Range (ATR)
- WYY 0.49
- PASG 0.04
- MACD
- WYY -0.22
- PASG 0.02
- Stochastic Oscillator
- WYY 5.06
- PASG 84.55
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.